News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
250 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17538)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry
A paper entitled ‘Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle’ by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry.
September 19, 2018
·
5 min read
Zimmer Biomet Launches its Mobi-C® Cervical Disc Replacement in Japan
Zimmer Biomet Holdings, Inc. announced the launch of its Mobi-C Cervical Disc for cervical total disc replacement (cTDR) in Japan.
September 19, 2018
·
4 min read
Pharm Country
Flexible Carestream Transportable X-ray System Completes Indiana Hospital’s Conversion to DR
Columbus Regional Health (Columbus, Ind.) has deployed a CARESTREAM DRX-Transportable System/Lite to complete its conversion to DR.
September 19, 2018
·
2 min read
Business
LENEXA TEEN AWARDED $25,000 FOR INVENTING TOOL TO MONITOR PARKINSON’S DISEASE
Erin Smith to be Named a 2018 Davidson Fellow
September 19, 2018
·
3 min read
Policy
Pharming Receives Complete Response Letter from FDA
Additional clinical trial data for prophylaxis of HAE requested
September 19, 2018
·
7 min read
Drug Development
NOXXON TO PRESENT CLINICAL TRIAL DATA AT FOURTH CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE ‘TRANSLATING SCIENCE INTO SURVIVAL’
Top-line data from NOX-A12 monotherapy trial plus available safety data from NOX-A12 / Keytruda® combination trial to be presented
September 19, 2018
·
3 min read
Pharm Country
Carestream Offers Advanced Second-Generation Metal Artifact Reduction Software for Its OnSight 3D Extremity System
Carestream Health has started shipping a new version of software for its CARESTREAM OnSight 3D Extremity System (see video link) that offers new standard features as well as optional enhanced metal artifact reduction software that can improve visibility of anatomy around metallic objects.
September 19, 2018
·
2 min read
Job Trends
Sekisui XenoTech Adds Rodent, Monkey Hepatocytes to Patented CryostaX® Product Line
Company Anticipates the End of Traditionally Cryopreserved Hepatocytes
September 19, 2018
·
4 min read
Policy
California Insurance Commissioner Files Fraud Complaint Against AbbVie
Illinois-based AbbVie is under fire from California’s Insurance Commissioner over allegations of a kickback scheme to support sales of blockbuster rheumatoid arthritis treatment Humira in the state.
September 19, 2018
·
3 min read
·
Alex Keown
Drug Development
Zealand Pharma’s Phase III Severe Hypoglycemia Rescue Treatment Hits the Mark in Clinical Trial
Days after selling future royalty streams for two Sanofi diabetes drugs for $205 million, Denmark-based Zealand Pharma announced its Phase III trial for severe insulin-induced hypoglycemia in diabetes hit all primary and key secondary endpoints that sets up potential regulatory approval.
September 19, 2018
·
2 min read
·
Alex Keown
Previous
4 of 25
Next